Benzinga | Oct 25, 2021 07:48AM EDT

Credit Suisse Maintains Outperform on HCA Healthcare, Raises Price Target to $298

Credit Suisse analyst Jonathan Yong maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $267 to $298.